Text Size
478 studies found for:    Thrombocytopenia: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed
Has Results 		A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma
Conditions: Chemotherapy-Induced Thrombocytopenia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Cancer;   Oncology;   Thrombocytopenia
Intervention: Biological: AMG 531
22 Completed
Has Results 		Optimal Platelet Dose Strategy for Management of Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Procedure: Medium Dose Prophylactic Platelet Transfusions;   Procedure: Lower Dose Prophylactic Platelet Transfusions;   Procedure: Higher Dose Prophylactic Platelet Transfusions
23 Completed SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
Conditions: Thrombocytopenia;   Thrombocytopaenia
Interventions: Drug: SB497115;   Other: Placebo
24 Active, not recruiting Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
Conditions: Chronic Lymphocytic Leukemia;   Thrombocytopenia
Interventions: Drug: Placebo;   Drug: Eltrombopag
25 Terminated
Has Results 		Safety/Efficacy Study of a Drug to Reduce Thrombocytopenia in Patients Receiving Chemotherapy for Ovarian, Fallopian Tube or Peritoneal Cancer
Conditions: Thrombocytopenia;   Neutropenia;   Lymphopenia;   Anemia
Interventions: Drug: TXA127;   Drug: Placebo
26 Terminated
Has Results 		Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures
Conditions: Non-alcoholic Steatohepatitis;   Chronic Liver Disease;   HCV;   NASH.;   HIV Infection;   Thrombocytopenia;   Hepatitis C Virus;   HBV;   Human Immunodeficiency Virus;   Liver Diseases;   Hepatitis B Virus
Interventions: Drug: Eltrombopag;   Drug: Placebo
27 Unknown † Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: recombinant human thrombopoietin
28 Recruiting Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia
Condition: Severe Thrombocytopenia
Intervention: Drug: oprelvekin
29 Active, not recruiting Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 (Study E5501-G000-203 AM02)
Condition: Thrombocytopenia
Intervention: Drug: E5501/Avatrombopag maleate
30 Completed Daclizumab to Treat Chronic Immune Thrombocytopenia
Condition: Thrombocytopenia
Intervention: Drug: Daclizumab
31 Recruiting The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenia
Intervention:
32 Completed Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome;   Thrombocytopenia
Intervention: Drug: Eltrombopag
33 Completed
Has Results 		Dose/ Schedule Finding Trial of AMG 531 for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Chemotherapy-Induced Thrombocytopenia;   Non-small Cell Lung Cancer;   Cancer;   Lung Neoplasms;   Oncology;   Solid Tumors;   Thrombocytopenia
Interventions: Biological: AMG 531 (romiplostim);   Drug: Placebo
34 Recruiting Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura
Interventions: Drug: romiplostim;   Drug: Placebo
35 Terminated Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
Condition: Chemotherapy Induced Thrombocytopenia
Intervention: Drug: AS101
36 Active, not recruiting Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Interventions: Drug: eltrombopag;   Drug: Placebo
37 Recruiting Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
38 Withdrawn Study of Eltrombopag in Platelet Refractory Thrombocytopenia
Condition: Thrombocytopenia
Intervention: Drug: Eltrombopag
39 Completed Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects
Condition: Thrombocytopaenia
Interventions: Drug: Eltrombopag;   Drug: Boceprevir;   Drug: Telaprevir
40 Active, not recruiting Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
Conditions: Chronic Thrombocytopenia;   Immune Thrombocytopenia
Interventions: Drug: E5501 - Avatrombopag maleate;   Drug: E5501 - Avatrombopag maleate Matching Placebo
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years